357 related articles for article (PubMed ID: 18694837)
1. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
Shin J; Lee SY; Kim SH; Kim YB; Cho SJ
Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837
[TBL] [Abstract][Full Text] [Related]
2. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
3. PET of brain amyloid and tau in mild cognitive impairment.
Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
[TBL] [Abstract][Full Text] [Related]
4. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
Lavretsky H; Siddarth P; Kepe V; Ercoli LM; Miller KJ; Burggren AC; Bookheimer SY; Huang SC; Barrio JR; Small GW
Am J Geriatr Psychiatry; 2009 Jun; 17(6):493-502. PubMed ID: 19472439
[TBL] [Abstract][Full Text] [Related]
5. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
[TBL] [Abstract][Full Text] [Related]
6. The merits of FDDNP-PET imaging in Alzheimer's disease.
Shin J; Kepe V; Barrio JR; Small GW
J Alzheimers Dis; 2011; 26 Suppl 3():135-45. PubMed ID: 21971458
[TBL] [Abstract][Full Text] [Related]
7. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
Small GW; Siddarth P; Burggren AC; Kepe V; Ercoli LM; Miller KJ; Lavretsky H; Thompson PM; Cole GM; Huang SC; Phelps ME; Bookheimer SY; Barrio JR
Arch Gen Psychiatry; 2009 Jan; 66(1):81-7. PubMed ID: 19124691
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
Vallabhajosula S
Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
[TBL] [Abstract][Full Text] [Related]
9. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.
Ito H; Shinotoh H; Shimada H; Miyoshi M; Yanai K; Okamura N; Takano H; Takahashi H; Arakawa R; Kodaka F; Ono M; Eguchi Y; Higuchi M; Fukumura T; Suhara T
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):745-54. PubMed ID: 24233004
[TBL] [Abstract][Full Text] [Related]
10. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.
Verhoeff NP; Wilson AA; Takeshita S; Trop L; Hussey D; Singh K; Kung HF; Kung MP; Houle S
Am J Geriatr Psychiatry; 2004; 12(6):584-95. PubMed ID: 15545326
[TBL] [Abstract][Full Text] [Related]
11. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.
Braskie MN; Klunder AD; Hayashi KM; Protas H; Kepe V; Miller KJ; Huang SC; Barrio JR; Ercoli LM; Siddarth P; Satyamurthy N; Liu J; Toga AW; Bookheimer SY; Small GW; Thompson PM
Neurobiol Aging; 2010 Oct; 31(10):1669-78. PubMed ID: 19004525
[TBL] [Abstract][Full Text] [Related]
12. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.
Driscoll I; Troncoso JC; Rudow G; Sojkova J; Pletnikova O; Zhou Y; Kraut MA; Ferrucci L; Mathis CA; Klunk WE; O'Brien RJ; Davatzikos C; Wong DF; Resnick SM
Acta Neuropathol; 2012 Dec; 124(6):823-31. PubMed ID: 22864813
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
14. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G
Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265
[TBL] [Abstract][Full Text] [Related]
15. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
Ercoli LM; Small GW; Siddarth P; Kepe V; Huang SC; Miller KJ; Lavretsky H; Bookheimer SY; Barrio JR; Silverman DH
Int J Geriatr Psychiatry; 2012 Oct; 27(10):1017-27. PubMed ID: 22383132
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.
Thompson PW; Ye L; Morgenstern JL; Sue L; Beach TG; Judd DJ; Shipley NJ; Libri V; Lockhart A
J Neurochem; 2009 Apr; 109(2):623-30. PubMed ID: 19226369
[TBL] [Abstract][Full Text] [Related]
17. Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints.
Merrill DA; Siddarth P; Raji CA; Emerson ND; Rueda F; Ercoli LM; Miller KJ; Lavretsky H; Harris LM; Burggren AC; Bookheimer SY; Barrio JR; Small GW
Am J Geriatr Psychiatry; 2016 Sep; 24(9):729-37. PubMed ID: 27421618
[TBL] [Abstract][Full Text] [Related]
18. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
19. Differential FDDNP PET patterns in nondemented middle-aged and older adults.
Ercoli LM; Siddarth P; Kepe V; Miller KJ; Huang SC; Cole GM; Lavretsky H; Bookheimer SY; Kim J; Phelps ME; Barrio JR; Small GW
Am J Geriatr Psychiatry; 2009 May; 17(5):397-406. PubMed ID: 19390297
[TBL] [Abstract][Full Text] [Related]
20. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.
Shoghi-Jadid K; Small GW; Agdeppa ED; Kepe V; Ercoli LM; Siddarth P; Read S; Satyamurthy N; Petric A; Huang SC; Barrio JR
Am J Geriatr Psychiatry; 2002; 10(1):24-35. PubMed ID: 11790632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
